Pharmacokinetics of escitalopram in Chinese healthy volunteers after oral administration of different doses

SI Tian-mei,QIU Jian-wen,LIU Yi,SUN Li-li,SU Yun-ai,ChunMei Guo,ZHANG Hong-yan,SHU Liang
DOI: https://doi.org/10.3321/j.issn:1003-3734.2008.09.017
2008-01-01
Abstract:Objective:To explore the pharmacokinetics of escitalopram tablets after single oral administra- tion of different doses in healthy Chinese volunteers.Methods:A total of 32 subjects participated in the study.Es- citalopram 10 mg,20 mg and 30 mg were given orally to 10,12 and 10 volunteers,respectively.Sequential blood samples were collected and escitalopram concentrations in plasma were determined by a validated high performance liquid chromatography with fluorescence detection.The pharmacokinetic parameters were calculated with DAS soft- ware.Results:Escitalopram disposition in oral administration was characterized by a two-compartment pharmacoki- netic and linear model.The main pharmacokinetic parameters after single doses of 10 mg,20 mg and 30 mg of es- citalopram were:C_(max) (20.91±4.94),(40.28±10.13),and (57.66±10.51)μg·L~(-1);T_(max)(3.80±1.23), (4.18±0.98),and (4.00±1.49)h;t_(1/2)(34.08±26.58),(36.02±23.68) and (36.95±11.58) h;AUC_(0~t), (846.8±466.7),(1437.5±535.5),and (2277.5±506.5)μg·h·L~(-1);AUC_(0~∞) (975.7±622.4), (1587.1±731.2) and (2496.6±707.4)μg·h·L~(-1),respectively.Individual variability was relatively large. The largest CV% value is 77.99%.The CL/F,AUC_(0~t),and AUC_(0~∞) on single dose were not significantly different (P>0.05) between male and female subjects.Conclusion:Escitalopram pharmacokinetics in healthy Chinese subjects at three different doses is characteristic of linear pharmacokinetics.
What problem does this paper attempt to address?